CAS: 184475-55-6 - Gefitinib hydrochloride

Formel: C₂₂H₂₅Cl₂FN₄O₃

InChl: InChI=1/C22H24ClFN4O3.ClH/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15;/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27);1H

Synonyme:

• 4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline hydrochloride
• N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine hydrochloride

4-Quinazolinamine,N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-,monohydrochloride

CAS: 184475-55-6

• Formel: C₂₂H₂₅Cl₂FN₄O₃
• Reinheit: 98%
• Farbe und Form: Solid
• Molekulargewicht: 483.3633

Gefitinib hydrochloride

CAS: 184475-55-6

Gefitinib HCl (ZD1839) is an oral EGFR inhibitor for cancer, blocking growth and EGFR activation …

• Formel: C₂₂H₂₅Cl₂FN₄O₃
• Farbe und Form: Solid
• Molekulargewicht: 483.36

Gefitinib hydrochloride

CAS: 184475-55-6

RIPK2 protein kinase inhibitor; EGFR inhibitor

• Formel: C₂₂H₂₄ClFN₄O₃·HCl
• Reinheit: Min. 95%
• Farbe und Form: Powder
• Molekulargewicht: 483.36 g/mol